|
Jun 25
|
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
|
|
Jun 18
|
With 48% stake, Standard BioTools Inc. (NASDAQ:LAB) seems to have captured institutional investors' interest
|
|
Jan 2
|
In the wake of Standard BioTools Inc.'s (NASDAQ:LAB) latest US$56m market cap drop, institutional owners may be forced to take severe actions
|